Quantinno Capital Management LP increased its position in Relx Plc (NYSE:RELX – Free Report) by 11.4% in the 4th quarter, HoldingsChannel reports. The fund owned 171,219 shares of the technology company’s stock after buying an additional 17,543 shares during the quarter. Quantinno Capital Management LP’s holdings in Relx were worth $7,777,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. LGT Group Foundation purchased a new stake in Relx during the 4th quarter valued at approximately $257,000. Paradigm Asset Management Co. LLC grew its holdings in Relx by 17.1% during the 4th quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company’s stock valued at $3,706,000 after buying an additional 11,900 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in Relx by 120.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 12,066 shares of the technology company’s stock valued at $548,000 after buying an additional 6,588 shares in the last quarter. Merit Financial Group LLC purchased a new stake in Relx during the 4th quarter valued at approximately $301,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in Relx by 19.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 143,483 shares of the technology company’s stock valued at $6,517,000 after buying an additional 23,183 shares in the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.
Relx Stock Up 1.9%
NYSE RELX opened at $54.09 on Friday. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company has a market capitalization of $100.11 billion, a P/E ratio of 29.08, a P/E/G ratio of 2.73 and a beta of 0.86. Relx Plc has a one year low of $43.28 and a one year high of $55.21. The stock has a 50 day moving average price of $50.99 and a 200-day moving average price of $48.84.
Relx Increases Dividend
Analysts Set New Price Targets
RELX has been the subject of a number of research analyst reports. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. The Goldman Sachs Group initiated coverage on shares of Relx in a report on Wednesday, March 26th. They set a “buy” rating for the company. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a report on Wednesday, April 16th. Finally, Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy”.
Get Our Latest Research Report on RELX
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Walmart Stock Alert: Big Price Move Expected Soon
- Golden Cross Stocks: Pattern, Examples and Charts
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- 3 Dividend Kings To Consider
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.